IONS logo

Ionis Pharmaceuticals (IONS) Cash from investing

annual CFI:

-$134.03M+$80.10M(+37.41%)
December 31, 2024

Summary

  • As of today (June 1, 2025), IONS annual cash flow from investing activities is -$134.03 million, with the most recent change of +$80.10 million (+37.41%) on December 31, 2024.
  • During the last 3 years, IONS annual CFI has fallen by -$328.93 million (-168.76%).
  • IONS annual CFI is now -148.83% below its all-time high of $274.48 million, reached on December 31, 2020.

Performance

IONS Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

quarterly CFI:

$170.46M+$102.25M(+149.89%)
March 31, 2025

Summary

  • As of today (June 1, 2025), IONS quarterly cash flow from investing activities is $170.46 million, with the most recent change of +$102.25 million (+149.89%) on March 31, 2025.
  • Over the past year, IONS quarterly CFI has increased by +$94.35 million (+123.98%).
  • IONS quarterly CFI is now -19.65% below its all-time high of $212.15 million, reached on December 31, 2022.

Performance

IONS quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

TTM CFI:

-$39.67M+$94.35M(+70.40%)
March 31, 2025

Summary

  • As of today (June 1, 2025), IONS TTM cash flow from investing activities is -$39.67 million, with the most recent change of +$94.35 million (+70.40%) on March 31, 2025.
  • Over the past year, IONS TTM CFI has dropped by -$227.29 million (-121.15%).
  • IONS TTM CFI is now -108.85% below its all-time high of $448.34 million, reached on March 31, 2021.

Performance

IONS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IONS Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+37.4%+124.0%-121.2%
3 y3 years-168.8%+159.3%+76.9%
5 y5 years-224.7%+279.4%+40.0%

IONS Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-168.8%+49.0%-19.6%+150.0%-121.2%+89.5%
5 y5-year-148.8%+49.0%-19.6%+150.0%-108.8%+89.5%
alltimeall time-148.8%+85.6%-19.6%+145.4%-108.8%+96.3%

IONS Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$170.46M(+149.9%)
-$39.67M(-70.4%)
Dec 2024
-$134.03M(-37.4%)
$68.21M(-120.0%)
-$134.03M(-41.5%)
Sep 2024
-
-$340.80M(-645.7%)
-$228.95M(-226.8%)
Jun 2024
-
$62.45M(-17.9%)
$180.55M(-3.8%)
Mar 2024
-
$76.11M(-384.9%)
$187.62M(-187.6%)
Dec 2023
-$214.13M(-18.5%)
-$26.71M(-138.9%)
-$214.13M(-965.8%)
Sep 2023
-
$68.71M(-1.2%)
$24.73M(-110.9%)
Jun 2023
-
$69.52M(-121.3%)
-$227.91M(-24.2%)
Mar 2023
-
-$325.64M(-253.5%)
-$300.73M(+14.5%)
Dec 2022
-$262.64M(-234.8%)
$212.15M(-215.3%)
-$262.64M(-30.8%)
Sep 2022
-
-$183.93M(+5466.9%)
-$379.67M(+414.7%)
Jun 2022
-
-$3.30M(-98.9%)
-$73.77M(-57.0%)
Mar 2022
-
-$287.55M(-402.3%)
-$171.50M(-188.0%)
Dec 2021
$194.91M(-29.0%)
$95.11M(-22.0%)
$194.91M(-32.2%)
Sep 2021
-
$121.97M(-220.7%)
$287.65M(+7.5%)
Jun 2021
-
-$101.03M(-228.1%)
$267.62M(-40.3%)
Mar 2021
-
$78.86M(-58.0%)
$448.34M(+63.3%)
Dec 2020
$274.48M(-765.0%)
$187.85M(+84.3%)
$274.48M(+22.1%)
Sep 2020
-
$101.94M(+27.9%)
$224.82M(+80.9%)
Jun 2020
-
$79.69M(-183.9%)
$124.28M(-288.0%)
Mar 2020
-
-$95.01M(-168.8%)
-$66.11M(+60.2%)
Dec 2019
-$41.27M(-95.6%)
$138.19M(+9799.1%)
-$41.27M(-91.8%)
Sep 2019
-
$1.40M(-101.3%)
-$505.67M(-37.9%)
Jun 2019
-
-$110.69M(+57.7%)
-$814.74M(-24.5%)
Mar 2019
-
-$70.17M(-78.5%)
-$1.08B(+16.1%)
Dec 2018
-$929.56M(+159.4%)
-$326.21M(+6.0%)
-$929.56M(+41.4%)
Sep 2018
-
-$307.67M(-18.0%)
-$657.57M(+31.5%)
Jun 2018
-
-$375.17M(-572.0%)
-$500.00M(+354.0%)
Mar 2018
-
$79.49M(-246.6%)
-$110.13M(-69.3%)
Dec 2017
-$358.29M(-733.0%)
-$54.21M(-63.9%)
-$358.29M(+26.5%)
Sep 2017
-
-$150.10M(-1121.4%)
-$283.28M(+48.9%)
Jun 2017
-
$14.70M(-108.7%)
-$190.27M(+25.6%)
Mar 2017
-
-$168.68M(-910.9%)
-$151.50M(-367.7%)
Dec 2016
$56.60M(-194.2%)
$20.80M(-136.4%)
$56.60M(-11.2%)
Sep 2016
-
-$57.09M(-206.8%)
$63.76M(-30.4%)
Jun 2016
-
$53.46M(+35.6%)
$91.57M(-259.9%)
Mar 2016
-
$39.43M(+41.0%)
-$57.27M(-4.6%)
Dec 2015
-$60.05M(-27.5%)
$27.96M(-195.5%)
-$60.05M(-56.7%)
Sep 2015
-
-$29.28M(-69.3%)
-$138.80M(+3.6%)
Jun 2015
-
-$95.39M(-360.3%)
-$134.01M(+88.7%)
Mar 2015
-
$36.65M(-172.2%)
-$71.02M(-14.3%)
Dec 2014
-$82.85M(-67.6%)
-$50.79M(+107.4%)
-$82.85M(-29.4%)
Sep 2014
-
-$24.49M(-24.4%)
-$117.33M(-45.7%)
Jun 2014
-
-$32.39M(-230.5%)
-$216.15M(+0.3%)
Mar 2014
-
$24.82M(-129.1%)
-$215.60M(-15.7%)
Dec 2013
-$255.73M(-1520.8%)
-$85.27M(-30.8%)
-$255.73M(+54.6%)
Sep 2013
-
-$123.31M(+287.2%)
-$165.42M(+213.8%)
Jun 2013
-
-$31.84M(+108.0%)
-$52.72M(-1739.8%)
Mar 2013
-
-$15.31M(-404.0%)
$3.21M(-82.1%)
Dec 2012
$18.00M(-83.3%)
$5.04M(-147.5%)
$18.00M(-60.3%)
Sep 2012
-
-$10.61M(-144.0%)
$45.33M(-9.8%)
Jun 2012
-
$24.09M(-4715.7%)
$50.24M(-1.1%)
Mar 2012
-
-$522.00K(-101.6%)
$50.79M(-53.0%)
Dec 2011
$108.03M(+355.9%)
$32.37M(-667.7%)
$108.03M(+57.9%)
Sep 2011
-
-$5.70M(-123.1%)
$68.41M(-54.4%)
Jun 2011
-
$24.64M(-56.6%)
$150.03M(+129.2%)
Mar 2011
-
$56.72M(-883.2%)
$65.45M(+176.2%)
Dec 2010
$23.69M(-111.2%)
-$7.24M(-109.5%)
$23.69M(+50.7%)
Sep 2010
-
$75.91M(-226.7%)
$15.72M(-115.8%)
Jun 2010
-
-$59.94M(-500.7%)
-$99.62M(+45.6%)
Mar 2010
-
$14.96M(-198.3%)
-$68.42M(-67.8%)
Dec 2009
-$212.29M(-9.4%)
-$15.21M(-61.4%)
-$212.29M(-6.9%)
Sep 2009
-
-$39.43M(+37.2%)
-$227.91M(-34.9%)
Jun 2009
-
-$28.73M(-77.7%)
-$350.12M(-0.1%)
Mar 2009
-
-$128.91M(+318.0%)
-$350.42M(+49.6%)
Dec 2008
-$234.25M
-$30.84M(-80.9%)
-$234.25M(+8.5%)
Sep 2008
-
-$161.64M(+456.9%)
-$215.80M(+96.3%)
Jun 2008
-
-$29.02M(+127.8%)
-$109.93M(+135.3%)
DateAnnualQuarterlyTTM
Mar 2008
-
-$12.74M(+2.8%)
-$46.73M(-16.0%)
Dec 2007
-$55.64M(+70.6%)
-$12.39M(-77.8%)
-$55.64M(-44.0%)
Sep 2007
-
-$55.77M(-263.2%)
-$99.40M(+188.6%)
Jun 2007
-
$34.18M(-257.8%)
-$34.45M(-49.0%)
Mar 2007
-
-$21.66M(-61.4%)
-$67.61M(+107.3%)
Dec 2006
-$32.61M(-169.3%)
-$56.14M(-711.7%)
-$32.61M(-187.5%)
Sep 2006
-
$9.18M(+802.5%)
$37.28M(-0.7%)
Jun 2006
-
$1.02M(-92.4%)
$37.54M(-33.0%)
Mar 2006
-
$13.34M(-3.0%)
$56.02M(+19.0%)
Dec 2005
$47.08M(-43.8%)
$13.74M(+45.5%)
$47.08M(-18.8%)
Sep 2005
-
$9.44M(-51.6%)
$57.97M(-2.2%)
Jun 2005
-
$19.50M(+343.7%)
$59.27M(+0.4%)
Mar 2005
-
$4.39M(-82.2%)
$59.07M(-29.5%)
Dec 2004
$83.73M(-653.8%)
$24.64M(+129.3%)
$83.73M(+58.6%)
Sep 2004
-
$10.74M(-44.3%)
$52.80M(+80.4%)
Jun 2004
-
$19.29M(-33.6%)
$29.26M(-35.0%)
Mar 2004
-
$29.06M(-561.5%)
$45.01M(-397.7%)
Dec 2003
-$15.12M(-75.0%)
-$6.30M(-50.8%)
-$15.12M(-18.5%)
Sep 2003
-
-$12.79M(-136.5%)
-$18.54M(+197.9%)
Jun 2003
-
$35.04M(-212.8%)
-$6.22M(-90.3%)
Mar 2003
-
-$31.07M(+219.7%)
-$64.13M(+6.2%)
Dec 2002
-$60.37M(-57.9%)
-$9.72M(+1963.5%)
-$60.37M(+13.6%)
Sep 2002
-
-$471.00K(-97.9%)
-$53.14M(-67.6%)
Jun 2002
-
-$22.87M(-16.2%)
-$164.17M(+5.1%)
Mar 2002
-
-$27.31M(+995.3%)
-$156.18M(+8.8%)
Dec 2001
-$143.49M(+50.4%)
-$2.49M(-97.8%)
-$143.49M(-16.7%)
Sep 2001
-
-$111.50M(+649.2%)
-$172.28M(+159.2%)
Jun 2001
-
-$14.88M(+1.8%)
-$66.46M(-20.5%)
Mar 2001
-
-$14.61M(-53.3%)
-$83.55M(-12.4%)
Dec 2000
-$95.38M(+1107.3%)
-$31.29M(+450.4%)
-$95.38M(+15.1%)
Sep 2000
-
-$5.68M(-82.2%)
-$82.89M(+11.1%)
Jun 2000
-
-$31.97M(+20.9%)
-$74.61M(+121.8%)
Mar 2000
-
-$26.44M(+40.6%)
-$33.64M(+325.8%)
Dec 1999
-$7.90M(-186.8%)
-$18.80M(-823.1%)
-$7.90M(-176.7%)
Sep 1999
-
$2.60M(-71.1%)
$10.30M(-39.1%)
Jun 1999
-
$9.00M(-1385.7%)
$16.90M(+482.8%)
Mar 1999
-
-$700.00K(+16.7%)
$2.90M(-68.1%)
Dec 1998
$9.10M(-159.9%)
-$600.00K(-106.5%)
$9.10M(-1616.7%)
Sep 1998
-
$9.20M(-284.0%)
-$600.00K(-96.0%)
Jun 1998
-
-$5.00M(-190.9%)
-$15.10M(+619.0%)
Mar 1998
-
$5.50M(-153.4%)
-$2.10M(-86.2%)
Dec 1997
-$15.20M(+34.5%)
-$10.30M(+94.3%)
-$15.20M(+53.5%)
Sep 1997
-
-$5.30M(-166.3%)
-$9.90M(-595.0%)
Jun 1997
-
$8.00M(-205.3%)
$2.00M(-47.4%)
Mar 1997
-
-$7.60M(+52.0%)
$3.80M(-133.6%)
Dec 1996
-$11.30M(+653.3%)
-$5.00M(-175.8%)
-$11.30M(+156.8%)
Sep 1996
-
$6.60M(-32.7%)
-$4.40M(-83.7%)
Jun 1996
-
$9.80M(-143.2%)
-$27.00M(-20.1%)
Mar 1996
-
-$22.70M(-1294.7%)
-$33.80M(+2153.3%)
Dec 1995
-$1.50M(-83.7%)
$1.90M(-111.9%)
-$1.50M(-54.5%)
Sep 1995
-
-$16.00M(-633.3%)
-$3.30M(-126.8%)
Jun 1995
-
$3.00M(-68.8%)
$12.30M(-1330.0%)
Mar 1995
-
$9.60M(+9500.0%)
-$1.00M(-89.1%)
Dec 1994
-$9.20M(+26.0%)
$100.00K(-125.0%)
-$9.20M(-30.3%)
Sep 1994
-
-$400.00K(-96.1%)
-$13.20M(-14.3%)
Jun 1994
-
-$10.30M(-835.7%)
-$15.40M(+316.2%)
Mar 1994
-
$1.40M(-135.9%)
-$3.70M(-49.3%)
Dec 1993
-$7.30M(-145.1%)
-$3.90M(+50.0%)
-$7.30M(-269.8%)
Sep 1993
-
-$2.60M(-285.7%)
$4.30M(-65.6%)
Jun 1993
-
$1.40M(-163.6%)
$12.50M(+4.2%)
Mar 1993
-
-$2.20M(-128.6%)
$12.00M(-25.9%)
Dec 1992
$16.20M(-137.1%)
$7.70M(+37.5%)
$16.20M(-189.0%)
Sep 1992
-
$5.60M(+522.2%)
-$18.20M(-49.4%)
Jun 1992
-
$900.00K(-55.0%)
-$36.00M(-12.8%)
Mar 1992
-
$2.00M(-107.5%)
-$41.30M(-5.5%)
Dec 1991
-$43.70M
-$26.70M(+118.9%)
-$43.70M(+157.1%)
Sep 1991
-
-$12.20M(+177.3%)
-$17.00M(+254.2%)
Jun 1991
-
-$4.40M(+1000.0%)
-$4.80M(+1100.0%)
Mar 1991
-
-$400.00K
-$400.00K

FAQ

  • What is Ionis Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual CFI year-on-year change?
  • What is Ionis Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly CFI year-on-year change?
  • What is Ionis Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals TTM CFI year-on-year change?

What is Ionis Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of IONS is -$134.03M

What is the all time high annual CFI for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual cash flow from investing activities is $274.48M

What is Ionis Pharmaceuticals annual CFI year-on-year change?

Over the past year, IONS annual cash flow from investing activities has changed by +$80.10M (+37.41%)

What is Ionis Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of IONS is $170.46M

What is the all time high quarterly CFI for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly cash flow from investing activities is $212.15M

What is Ionis Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, IONS quarterly cash flow from investing activities has changed by +$94.35M (+123.98%)

What is Ionis Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of IONS is -$39.67M

What is the all time high TTM CFI for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high TTM cash flow from investing activities is $448.34M

What is Ionis Pharmaceuticals TTM CFI year-on-year change?

Over the past year, IONS TTM cash flow from investing activities has changed by -$227.29M (-121.15%)
On this page